Gerard has 20 years of experience in the pharmaceutical and global health space. He has worked in the vaccine arena for the past 13 years, and led the new vaccine planning function at Merck. More recently he was executive director for emerging markets strategy at Merck responsible for developing commercial strategies to drive access to Merck’s portfolio of vaccines and pharmaceuticals
Gerard spent more than 3 years working at the Bill & Melinda Gates Foundation where he supported the HIV, TB and Malaria teams, and worked closely with a range of partners including multi-national corporations, emerging market manufacturers, WHO, UNICEF, GAVI and others to support delivery of new vaccines and the eradication of polio.
In addition, while at BMGF, Gerard negotiated a number of partnerships to drive access to new vaccines. He was responsible for assessments of new technologies for IPV to support polio eradication as well as partner/supplier assessments including leadership of technical, financial and legal diligence efforts for multiple manufacturers.